Drug intelligence / Profile preview

68Ga-XT771

Development stage
Unknown
Lead developer
Sinotau Pharmaceutical Group
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**68Ga-XT771** is a novel radiopharmaceutical imaging agent labeled with the radionuclide gallium-68 (^68Ga), developed for use in positron emission tomography (PET) imaging. It specifically targets **carbonic anhydrase IX (CAIX)** and **carbonic anhydrase XII (CAXII)** proteins, which are highly expressed in certain tumors, notably **glioblastoma** and **clear cell renal cell carcinoma**. By binding to these proteins, 68Ga-XT771 enables the visualization of tumor cells in vivo using PET/CT imaging. The agent is currently being evaluated in early-phase clinical trials for its diagnostic utility and safety in oncologic imaging[1][2][3][5][6][7][10].

Other names
[68Ga]Ga-XT771
02

Targets

CA12 (Carbonic anhydrase XII)CA9 (Carbonic anhydrase IX)

Beyond the preview

Go deeper on 68Ga-XT771.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-XT771.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call